Total Payments
$4,449
2024 Payments
$329.45
Companies
32
Transactions
236
Medicare Patients
648
Medicare Billing
$65,874
Payment Breakdown by Category
Food & Beverage$4,449 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,449 | 236 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,507 | 78 | $0 (2024) |
| Lilly USA, LLC | $342.74 | 19 | $0 (2024) |
| Amgen Inc. | $327.97 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $323.15 | 15 | $0 (2023) |
| ABBVIE INC. | $309.46 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $291.96 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $195.96 | 13 | $0 (2024) |
| PFIZER INC. | $161.01 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $134.86 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $115.52 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $329.45 | 15 | Novo Nordisk Inc ($97.17) |
| 2023 | $873.62 | 43 | Novo Nordisk Inc ($281.59) |
| 2022 | $809.13 | 40 | Novo Nordisk Inc ($280.10) |
| 2021 | $551.84 | 29 | Novo Nordisk Inc ($213.08) |
| 2020 | $255.72 | 14 | Novo Nordisk Inc ($93.91) |
| 2019 | $658.38 | 36 | Novo Nordisk Inc ($273.87) |
| 2018 | $460.49 | 27 | Novo Nordisk Inc ($186.09) |
| 2017 | $510.60 | 32 | Merck Sharp & Dohme Corporation ($90.95) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | bioMerieux Inc | BIOFIRE SPOTFIRE Respiratory (R) Panel (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Diagnostics | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: VACCINE | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Inflammation | ||||||
| 06/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.69 | General |
| 05/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Oncology | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Respiratory | ||||||
| 04/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 01/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Diabetes | ||||||
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Gastroenterology | ||||||
| 12/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: VACCINES | ||||||
| 11/22/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Diabetes | ||||||
| 11/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: VACCINES | ||||||
| 11/08/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Inflammation | ||||||
| 10/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: Diabetes | ||||||
| 10/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 114 | 228 | $40,559 | $12,842 |
| 2022 | 8 | 190 | 341 | $49,217 | $21,454 |
| 2021 | 9 | 185 | 286 | $38,658 | $16,633 |
| 2020 | 7 | 159 | 243 | $36,913 | $14,945 |
Total Patients
648
Total Services
1,098
Medicare Billing
$65,874
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 92 | $27,754 | $8,339 | 30.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $5,598 | $2,309 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 26 | $5,678 | $1,684 | 29.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 34 | $838.00 | $323.68 | 38.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 22 | 59 | $691.00 | $186.60 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 121 | $27,197 | $11,615 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $7,425 | $3,777 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 41 | $6,678 | $3,054 | 45.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 15 | 20 | $5,040 | $2,032 | 40.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $660.00 | $383.64 | 58.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 33 | $858.00 | $316.49 | 36.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 23 | 63 | $1,071 | $203.89 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 19 | 24 | $288.00 | $71.19 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 76 | $16,933 | $7,839 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $6,600 | $3,430 | 52.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 33 | $5,178 | $2,017 | 39.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 25 | $5,236 | $1,938 | 37.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 14 | $2,022 | $624.59 | 30.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 19 | 29 | $754.00 | $281.59 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $825.00 | $277.95 | 33.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 26 | 54 | $918.00 | $177.12 | 19.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 16 | $192.00 | $48.00 | 25.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 74 | $15,472 | $5,879 | 38.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 25 | 44 | $9,152 | $4,265 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 14 | 14 | $3,850 | $1,751 | 45.5% |
About Dr. Susan Wiskowski, MD
Dr. Susan Wiskowski, MD is a Family Medicine healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881616795.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Wiskowski, MD has received a total of $4,449 in payments from pharmaceutical and medical device companies, with $329.45 received in 2024. These payments were reported across 236 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,449).
As a Medicare-enrolled provider, Wiskowski has provided services to 648 Medicare beneficiaries, totaling 1,098 services with total Medicare billing of $65,874. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hartford, CT
- Active Since 07/24/2006
- Last Updated 06/21/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881616795
Products in Payments
- Ozempic (Drug) $596.43
- XIFAXAN (Drug) $322.83
- Rybelsus (Drug) $296.76
- UBRELVY (Drug) $204.92
- Tresiba (Drug) $195.23
- MOUNJARO (Drug) $193.63
- JANUVIA (Drug) $179.35
- TRULICITY (Drug) $149.11
- Prolia (Biological) $148.47
- TRELEGY ELLIPTA (Drug) $146.02
- ELIQUIS (Drug) $92.90
- VRAYLAR (Drug) $88.78
- XARELTO (Drug) $84.48
- RYBELSUS (Drug) $71.42
- Victoza (Drug) $69.95
- Cologuard Collection Kit (Device) $61.68
- SHINGRIX (Biological) $57.24
- LINZESS (Drug) $56.35
- Otezla (Drug) $54.34
- EVENITY (Biological) $54.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hartford
Mohammad Samer Younes, M.d, M.D
Family Medicine — Payments: $16,845
Family Medicine $16,845
Mark Belsky, Md, MD
Family Medicine — Payments: $7,778
Family Medicine $7,778
Dr. Nieves Hornbeck, M.d, M.D
Family Medicine — Payments: $7,619
Family Medicine $7,619
Charlecinth Roberts, Md, MD
Family Medicine — Payments: $7,389
Family Medicine $7,389
Sama Alvi, M.d, M.D
Family Medicine — Payments: $4,362
Family Medicine $4,362
Ms. Magilta Joseph, Msm Aprn Fnp-Bc, MSM APRN FNP-BC
Family Medicine — Payments: $2,876
Family Medicine $2,876